Effect of prostatic stromal difference on pathogenesis of benign prostatic hyperplasia
Relationship between prostatic specific antigen and clinical symptomatic parameters in benign prostatic hyperplasia with lower urinary tract symptoms
METHODS Experimental prostatic hyperplasia was produced in the mouse by testosterone injection. The prostate index and pathology changes of prostatic tissues were observed.
Controlled clinical study of Harnal on 103 patients with benign prostatic hyperplasia
Conclusion:We report the histopathologic distinctions among BCH,atypical hyperplasia,basaloid carcinoma,prostatic intraepithelial neoplasia,adenocarcinoma,adenosis,and atrophy.
Objective:To evaluate the causes and management of postoperative massive bleeding of benign prostatic hyperplasia (BPH) patients treated with transurethral resection of prostate (TURP).
Other reported cases in the prostate include a clear cell carcinoma of the prostatic utricle in a 16 year old boy reported from Uruguay and a renal cell type of prostatic carcinoma which lacked hobnail cells and had staining patterns similar to renal cell carcinoma.
Microcirculation changes in benigh prostatic hyperplasia and prostatic carcinoma
Diffusion-weighted imaging in diagnosis of prostatic diseases
Mixed prostatic carcinoma:a report of 5 patients and literature review
Nursing Care for Patients with benign prostatic hyperplasia after transurethral vapo-resection of prostate
Methods The clinical data of3 cases of prostatic abscess were studied, and the related literatures were reviewed.
Conclusion: Qianlie Zhitong Tang is an effective prescription in treating CPPS, whose mechanism may be related to regulating the content of prostatic histiocytic factors.
examination of prostatic fluid
Intracavitary therapy for benign prostatic hyperplasia with bladder stone
Clinical value of prostatic biopsy under the guidance of transrectal power Doppler ultrasonography
TURP with transurethral cystolithotripsy by ultrasound lithotripsy and pneumatic in the treatment of bladder calculi with benign prostatic hyperplasia
Objective To investigate perioperative nursing of benign prostatic hypertrophy (BPH) patients undergoing transurethral Holmium: Yttrium-Alumium-Garnet laser prostatectomy(HOL-RP).
trans-urethral radio-frequency prostatic thermal treatment
Study on phenylethylamines new compounds against benign prostatic hyperplasia
Cloning of tumor-specific survivin promoter and the identification of its transcriptional activities in human prostatic carcinoma
prostatic hypertrophy
Prostate professional: mainly in prostatitis, prostatic hyperplasia, prostate, prostatic cyst, prostate cancer and other disease clinical research and treatment.
The clinical feature of advanced aged patients with benign prostatic hyperplasia and the efficiency of transurethral vaporization resection of the prostate
Evaluation of MRI and MRS in the diagnosis of prostatic cancer and benign prostatic hyperplasia
Nickel-titanium shape-memory alloy stent management of urinary stasis caused by benign prostatic hyperplasia in high risk patient
Plasmakinetic transurethral retrograde dissection of prostate for benign prostatic hyperplasia
However, the Stanford researchers concluded that the PSA test is quite accurate at indicating the size of the prostate gland, meaning that it is a direct measure of benign prostatic hyperplasia.
Three main problems can occur in the prostate gland: inflammation or infection, called prostatitis; enlargement, called benign prostatic hyperplasia (BPH); and cancer.
Expression of prostatic specific membrane antigen and prostatic specific antigen in prostatic adenocarcinoma tissue
Panoxadiol saponin enhances the apoptotic effect of cisplatin on prostatic cancer cells DU145
Study on the diagnostic criteria of benign prostatic hyperplasia in MRS